Investor Relations
-
Message from the Chairman and CEO
We are working to meet the expectations of our shareholders and investors by enhancing corporate value.
Message from the Chairman and CEO
We are working to meet the expectations of our shareholders and investors by enhancing corporate value.
-
Stock Price
Last-
Change-
Chart
IR Topics
-
News Releases
- Sysmex Forms Strategic Alliance with QIAGEN for Providing Global Cancer Companion Diagnostics that Uses Ultra-sensitive Liquid Biopsy NGS Technology (PDF：205KB)
-
News Releases
- Our Views and Policy regarding Investment Unit Reduction (PDF：94KB)
-
IR Topics
- Notice of Resolutions at the 54th Ordinary General Meeting of Shareholders
-
News Releases
-
Sysmex Obtains IVDR Certification for LYNOAMP™ CK19 E, a Gene Amplification Detection Reagent
- Prompt response to legislative changes in the European region that demand greater product safety - (PDF：184KB) -
News Releases
- Th2 Chemokine TARC Kit "HISCL™ TARC Assay Kit" is Approved for an Additional Indication as an Auxiliary for Assessment of COVID-19 Aggravation risk (PDF：210KB)
Download the Latest IR Materials
Click Here
for File Details
Data Included in the Zip File
Consolidated Financial Results for the Fiscal Year Ended March 31, 2021- Financial Statements
- Presentation
- Financial Data
